UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S. needs to be "less confusing, less complex and less costly" during the company's first earnings call since the murder of Brian Thompson,
U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over 170 points and ending the day at 19,338.29.
U.S. stock indexes drifted lower following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies
UnitedHealth Group reported $14.4 billion in 2024 profits as its UnitedHealthcare health insurance and Optum provider services overcame rising costs and a cyberattack.
The U.S. government said late Friday that it will increase Medicare Advantage reimbursement rates by 2.2% next year, that along with a 2.1% boost in 'risk score' will likely contribute to an extra $21 billion in payments to private insurers.
In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its shares to fall in early morning trading despite quarterly profit beating projections.
Thursday's trading session has presented significant movements among stocks, particularly within the mega-cap and large-cap segments. Market participants have witnessed notable declines in heavyweight stocks like UnitedHealth Group (UNH) and Tesla Motors (NASDAQ:TSLA),
UnitedHealth (UNH) stock fell after the company's Q4 2024 results showed a revenue miss amid rising medical expenses, but earnings exceed expectations. Read more here.
United Healthcare Insurance Co. struck a deal to resolve three proposed class actions saying it wrongly refused to cover a cancer treatment patients say is more effective—but more expensive—than traditional radiation.
UnitedHealth's OptumRx to pass 100% of drug rebates to clients by 2028, but critics say GPO structure may still hide true discounts, as CEO Witty addresses pricing concerns
Tesla Inc senior executive and Cybertruck lead engineer Wes Morrill on Monday pitched health reasons to adopt electric vehicles over environmental concerns, following President Donald Trump's cancelation of former President Joe Biden's EV targets.
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.